Harris John David Insider Trades

Insider Trading History

Track insider trading activity for Harris John David. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Plus Therapeutics
Plus Therapeutics PSTV
VP And GM Cell Therapy
Holding Value $0 0 shares
Last Trade
Nov 28, 2017 Sale (In The Money)Reported as In The Money on SEC Form 4.
$71.3k 1 shares
$71,250.00
$5.74
Plus Therapeutics
Plus Therapeutics PSTV
VP And GM Cell Therapy
Holding Value $10.3k 1,800 shares
Last Trade
Nov 28, 2017 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$128M 1,800 shares
$71,250.00
$5.74
Plus Therapeutics
Plus Therapeutics PSTV
VP And GM Cell Therapy
Holding Value $5.75 1 shares
Last Trade
Nov 28, 2017 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$71.3k 1 shares
$71,250.00
$5.74
Plus Therapeutics
Plus Therapeutics PSTV
VP And GM Cell Therapy
Holding Value $241k 42,000 shares
Last Trade
Mar 08, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.2B 42,000 shares
$290,625.00
$5.74
Plus Therapeutics
Plus Therapeutics PSTV
VP And GM Cell Therapy
Holding Value $179k 31,100 shares
Last Trade
Mar 08, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.04B 31,100 shares
$290,625.00
$5.74
Plus Therapeutics
Plus Therapeutics PSTV
VP And GM Cell Therapy
Holding Value $40.2k 7,000 shares
Last Trade
Aug 10, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$45.8k 2,500 shares
$18.30
$5.74
Plus Therapeutics
Plus Therapeutics PSTV
VP And GM Cell Therapy
Holding Value $0 0 shares
Last Trade
Jun 15, 2016 Sale (In The Money)Reported as In The Money on SEC Form 4.
$1.01B 2,500 shares
$405,000.00
$5.74
Plus Therapeutics
Plus Therapeutics PSTV
VP And GM Cell Therapy
Holding Value $25.9k 4,500 shares
Last Trade
Jun 15, 2016 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$1.01B 2,500 shares
$405,000.00
$5.74
Plus Therapeutics
Plus Therapeutics PSTV
VP And GM Cell Therapy
Holding Value $7.18k 1,250 shares
Last Trade
Jun 15, 2016 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$506M 1,250 shares
$405,000.00
$5.74
Plus Therapeutics
Plus Therapeutics PSTV
VP And GM Cell Therapy
Holding Value $11.5k 2,000 shares
Last Trade
May 13, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$998M 2,000 shares
$498,750.00
$5.74
Plus Therapeutics
Plus Therapeutics PSTV
VP And GM Cell Therapy
Holding Value $3.93M 684,830 shares
Last Trade
Jan 04, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$187B 349,830 shares
$534,375.00
$5.74
Plus Therapeutics
Plus Therapeutics PSTV
VP And GM Cell Therapy
Holding Value $1.92M 335,000 shares
Last Trade
Nov 11, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$349B 335,000 shares
$1,040,625.00
$5.74

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up